Scarica l'app Stockscreener
95.72
1.97%
-1.92
Pre-mercato:
95.65
-0.07
-0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$97.64
Aprire:
$97.9
Volume 24 ore:
7.21M
Relative Volume:
0.83
Capitalizzazione di mercato:
$141.90B
Reddito:
$19.35B
Utile/perdita netta:
$2.78B
Rapporto P/E:
51.20
EPS:
1.8696
Flusso di cassa netto:
$3.82B
1 W Prestazione:
+0.25%
1M Prestazione:
+3.39%
6M Prestazione:
-7.25%
1 anno Prestazione:
+0.89%
Intervallo 1D:
$95.34
$97.90
Intervallo di 1 settimana:
$95.10
$100.90
Portata 52W:
$85.98
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Confronta BSX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
95.72 | 144.75B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
124.64 | 218.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
361.37 | 140.56B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.95 | 125.03B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.01 | 49.40B | 5.88B | 1.34B | 799.60M | 2.3489 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific plans 300,000-square-foot expansion at Maple Grove campus - The Business Journals
Boston Scientific to acquire California bladder dysfunction treatment company - Worcester Business Journal
Boston Scientific to Buy Urinary Incontinence Treatment Maker Valencia Technologies - Medical Product Outsourcing
Global Catheters Market Size to Hit USD 55.58 Billion by 2033, Driven by Rising Cardiovascular and Urological Procedures – SNS Insider - GlobeNewswire Inc.
Boston Scientific To Acquire Valencia Technologies - Nasdaq
Boston Scientific to acquire urinary incontinence treatment developer Valencia Technologies - MassDevice
Boston Scientific to acquire Valencia Technologies for urology expansion - Investing.com
Boston Scientific Corporation (BSX) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Med tech company Boston Scientific readies for new Austin offices - MSN
Did Analyst Upgrades and Pipeline Optimism Just Shift Boston Scientific's (BSX) Investment Narrative? - Yahoo Finance
Boston Scientific plans move to former Scorpion building - Santa Clarita Valley Signal
Boston Scientific’s AXIOS™ Gastroenterostomy Trial Paused: What Investors Should Watch - TipRanks
What technical signals suggest for Boston Scientific Corporation stock2025 Trading Recap & Daily Oversold Stock Bounce Ideas - ulpravda.ru
Boston Scientific Corp.: How a Medtech Powerhouse Is Re?Wiring the Future of Minimally Invasive Care - AD HOC NEWS
Boston Scientific reportedly plans to consolidate some Texas operations with new facility - MassDevice
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? - Finviz
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Boston Scientific Earnings Preview: What to Expect - Yahoo Finance
Can Boston Scientific Corporation stock continue upward trendDividend Aristocrats List & Small Capital Trading Growth - ulpravda.ru
Boston Scientific (BSX) Just Overtook the 50-Day Moving Average - Yahoo Finance
If You Invested $1000 in Boston Scientific 10 Years Ago, This Is How Much You'd Have Now - Yahoo Finance
Med tech company begins renovations for new South Congress offices - Austin American-Statesman
We Think Boston Scientific (NYSE:BSX) Can Manage Its Debt With Ease - Yahoo Finance
Boston Scientific (BSX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Corporation (BSX) Stock Analysis: A 32.89% Potential Upside Beckons Investors - DirectorsTalk Interviews
Boston Scientific Stock: Steady Beat, Subtle Volatility – What The Market Is Really Pricing In - AD HOC NEWS
JARISLOWSKY FRASER Ltd Trims Stake in Boston Scientific Corporation $BSX - MarketBeat
Synergy Asset Management LLC Acquires 479,593 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp Is Quietly Winning Wall Street – But Is BSX Actually Worth Your Money? - AD HOC NEWS
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results - Finviz
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results – Company AnnouncementFT.com - Financial Times
A Look Into Boston Scientific Inc's Price Over Earnings - Benzinga
Vanderbilt University Has $2.55 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
List of 56 Acquisitions by Boston Scientific (Jan 2026) - Tracxn
How Is Boston Scientific's Cardiovascular Growth Path Shaping Up? - The Globe and Mail
Calamos Wealth Management LLC Buys 53,252 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Boston Trust Walden Corp - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Allspring Global Investments Holdings LLC - MarketBeat
Does Boston Scientific (NYSE:BSX) Deserve A Spot On Your Watchlist? - Yahoo Finance
Boston Scientific Corp. stock: quiet tape, loud expectations as Wall Street leans bullish - AD HOC NEWS
Sowell Financial Services LLC Sells 28,806 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stock Position Lessened by Ethic Inc. - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
CathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius® System Version 3.5 - Quantisnow
A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook - Insider Monkey
VCI Wealth Management LLC Invests $1.26 Million in Boston Scientific Corporation $BSX - MarketBeat
Norden Group LLC Increases Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Acquired by Brookstone Capital Management - MarketBeat
What Analysts Think Is Changing In The Boston Scientific Growth Story - Yahoo Finance
Should New Institutional Support and Analyst Optimism Around Farapulse Reshape Boston Scientific (BSX) Investors’ Thesis? - Yahoo Finance
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):